Sarepta Therapeutics Announces Third Quarter 2017 Financial Results and Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Sarepta Therapeutics Announces Third Quarter 2017 Financial Results and Recent Corporate Developments

Sarepta Therapeutics (SRPT) Tops Q3 EPS by 7c; Raises FY Revenue outlook

October 25, 2017 4:08 PM EDT

Sarepta Therapeutics (NASDAQ: SRPT) reported Q3 EPS of ($0.78), $0.07 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $46 million versus the consensus estimate of $40.77 million.

GUIDANCE:

Sarepta Therapeutics sees FY2017 revenue of $150-155 million, versus the consensus of... More